Document is current

Article History

Accepted: 14 March 2025

First Online: 15 April 2025

Competing interests

: S.V. L. has an advisory/consulting role for Cystotech. M.D.G. has received consultant fees from BioMotiv, Janssen, Merck, Dendreon, GlaxoSmithKline, Lilly, Astellas, Genentech, Bristol Myers Squibb, Novartis, Pfizer, EMD Serono, AstraZeneca, Seattle Genetics, Incyte, Aileron Therapeutics, Dracen, Inovio Pharmaceuticals and Numab; has received research funding from Janssen, Merck, Dendreon, Novartis, Bristol Myers Squibb, AstraZeneca and Genentech/Roche; and owns stock in Rappta Therapeutics outside the submitted work; he also has a patent entitled Methods and compositions for treating cancer and related methods (Mount Sinai School of Medicine; 20120322792). T.P. has received honoraria from Astellas, AstraZeneca, Bristol Myers Squibb, Eisai, Exelixis, Gilead, Incyte, Ipsen, Johnson & Johnson, Mashup Media, Merck, MSD, Novartis, Pfizer, Roche and Seagen; has provided consulting or advisory services for Astellas, AstraZeneca, Bristol Myers Squibb, Eisai, Exelixis, Incyte, Ipsen, Johnson & Johnson, Mashup Media, Merck, MSD, Novartis, Pfizer, Roche and Seagen; has received research funding from Astellas, AstraZeneca, Bristol Myers Squibb, Eisai, Exelixis, Ipsen, Johnson & Johnson, Merck, MSD, Novartis, Pfizer, Roche and Seagen; and has received travel and accommodation support from AstraZeneca, Ipsen, MSD, Pfizer and Roche. J.B.J. is an advisory board member for Ferring, Roche, Cepheid, Urotech, Olympus, AMBU, Janssen and Cystotech; is a speaker for medac, Olympus, Intuitive Surgery and Photocure ASA; and has research collaborations with medac, Photocure ASA, Roche, Ferring, Olympus, Intuitive Surgery, Astellas, Cepheid, Nucleix, Urotech, Pfizer, AstraZeneca, MeqNordic, Laborie, VingMed, AMBU, and Cystotech. L.D. has sponsored research agreements with C2i Genomics, Veracyte, Natera, AstraZeneca, Photocure and Ferring; has an advisory/consulting role for Ferring, MSD, UroGen and Cystotech; has received speaker honoraria from AstraZeneca, Pfizer and Roche; has received travel support from MSD; is a board member for BioXpedia. The other authors declare no competing interests.